Home › Therapeutic areas › Respiratory › Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome (3 companies)
Companies with an active program in Acute Respiratory Distress Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics | HematologyOphthalmology+2 Rare | 1 | Approved | $111M | 10 |
| INKT | MiNK Therapeutics | ImmunologyOncology+1 Rare | 1 | Phase 2 | $52.8M | 8 |
| OMER | Omeros | HematologyNeurology+2 Rare | 1 | Approved | $1.22B | 6 |
No companies match.